SPLASH BEVERAGE GROUP, INC. 8-K

What Happened
Splash Beverage Group, Inc. (SBEV) announced via a Form 8-K dated July 6, 2026 (Item 7.01, Regulation FD Disclosure) that it has entered into an exclusive global licensing agreement with Argent BioPharma Limited (ASX/LSE: RGT). The company furnished a press release about the agreement as Exhibit 99.1 to the filing.

Key Details

• Filing date: July 6, 2026 (Form 8-K, Item 7.01 Regulation FD Disclosure).
• Counterparty: Argent BioPharma Limited (ticker: RGT on ASX and LSE).
• Disclosure: Press release announcing the agreement is attached as Exhibit 99.1.
• Financial terms or commercial details were not included in the 8-K (no monetary figures or contract terms provided).

Why It Matters
An exclusive global licensing agreement is potentially material because it may affect Splash Beverage Group’s product portfolio and commercial opportunities. The 8-K serves to inform investors of the deal but does not provide financial or operational terms; investors should read the attached press release and watch for future filings or announcements that disclose specific terms, timelines, or expected impacts on the company's business.